The Value of FeNO in Predicting Airway Eosinophilic Inflammation

NCT04885738 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2052

Last updated 2021-05-13

No results posted yet for this study

Summary

To investigate and compare the value of FeNO, blood Eos, serum TIgE in predicting the airway eosinophilic inflammationin chronic cough, asthma and COPD.

Conditions

  • Biomarkers
  • Airway Inflammation

Interventions

OTHER

no intervention

For Chronic Cough,follow《Guidelines for the diagnosis and treatment of cough》(2015). For Asthma, follow GINA For COPD, follow GOLD.

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Huizhou Third People's Hospital

    collaborator UNKNOWN
  • Tongji Hospital

    collaborator OTHER
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • The First People's Hospital of Yunnan

    collaborator OTHER
  • Inner Mongolia People's Hospital

    collaborator OTHER
  • Second Hospital of Jilin University

    collaborator OTHER
  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • Kefang Lai, phD · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2022-03-25
Completion
2022-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04885738 on ClinicalTrials.gov